Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - HEAT BIOLOGICS, INC. | htbx-20191231x10k.htm |
| EX-32.2 - CERTIFICATION - HEAT BIOLOGICS, INC. | htbx-20191231ex3224b4793.htm |
| EX-32.1 - CERTIFICATION - HEAT BIOLOGICS, INC. | htbx-20191231ex3215f04f5.htm |
| EX-31.2 - CERTIFICATION - HEAT BIOLOGICS, INC. | htbx-20191231ex312a31961.htm |
| EX-31.1 - CERTIFICATION - HEAT BIOLOGICS, INC. | htbx-20191231ex311eb535b.htm |
| EX-21.1 - SUBSIDIARIES - HEAT BIOLOGICS, INC. | htbx-20191231ex2117c859b.htm |
| EX-4.20 - DESCRIPTION OF SECURITIES - HEAT BIOLOGICS, INC. | htbx-20191231ex4203b5d66.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
Heat Biologics, Inc.
Morrisville, North Carolina
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (No. 333-224039 and No. 333-234105), Form S3 (No. 333-214868 and No. 333-221201) and Form S-8 (No. 333-193453, No. 333-196763, No. 333-207108, No. 333-213133, No. 333-219238, No. 333-227699, No. 333-233352 and No. 333-237137) of Heat Biologics, Inc. of our report dated March 30, 2020, relating to the consolidated financial statements, which appear in this Form 10-K. Our report on the consolidated financial statements contains an explanatory paragraph regarding Heat Biologics, Inc.'s ability to continue as a going concern.
/s/ BDO USA, LLP
BDO USA, LLP
Raleigh, NC
March 30, 2020